Inhibition of human anthracycline reductases by emodin — A possible remedy for anthracycline resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of human anthracycline reductases by emodin — A possible remedy for anthracycline resistance

Published:2016-02 Issue: Volume:293 Page:21-29
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Hintzpeter Jan,Seliger Jan Moritz,Hofman Jakub,Martin Hans-Joerg,Wsol Vladimir,Maser Edmund

Funder

Deutsche Forschungsgemeinschaft

European Social Fund

state budget of the Czech Republic

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference70 articles.

1. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction;Ax;Biochem. Pharmacol.,2000

2. Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin;Bains;Drug Metab. Dispos.,2008

3. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin;Bains;Drug Metab. Dispos.,2009

4. Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin;Bains;J. Pharmacol. Exp. Ther.,2010

5. Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism;Bains;J. Pharmacol. Exp. Ther.,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming;Molecular Aspects of Medicine;2023-10

2. Research Progress and New Perspectives of Anticancer Effects of Emodin;The American Journal of Chinese Medicine;2023-01

3. Development of transgenic mice overexpressing mouse carbonyl reductase 1;Molecular Biology Reports;2022-11-09

4. Inhibition of human carbonyl reducing enzymes by plant anthrone and anthraquinone derivatives;Chemico-Biological Interactions;2022-02

5. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis;Chinese Medicine;2021-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3